We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Open Tube Hematology Analyzer Is Compact and Versatile

By LabMedica International staff writers
Posted on 05 Nov 2009
An open tube analyzer enables flexible and convenient in vitro diagnostic (IVD) testing of whole blood specimens. More...


The compact hematology analyzer is ideal for situations where there are various types of sample tubes and sample types. Called Pentra ES60, it covers 26 parameters including complete blood cell (CBC) and differential (DIFF) counts. It also counts atypical lymphocytes and large immature cells and processes up to 60 samples an hour.

The Pentra ES 60's integrated multi-distribution sampling system (MDSS) enables micro-sampling (30 µL in CBC mode and 53 µL in CBC + DIFF), making the analyzer ideal for pediatric or geriatric sample types, where only small sample volumes are available.

Ideal as a standalone analyzer for small to medium sized laboratories, the Pentra ES 60 is a compact bench top system, designed to take up minimal workspace. The analyzer's Windows-based software makes it simple to use. It is adaptable to enable threshold adjustments for specific sample types. The simplicity of the analyzer's design also means there is no daily maintenance, just one automatic start up and shut down each day.

Launched by Horiba Medical (Moulton Park, UK) the Pentra ES 60 five-part differential (Diff) analyzer expands the company's open tube hematology analysis range. To ensure system security, the Pentra ES 60 can be set up with password-protected access, which also enables full audit trails for quality assurance purposes.

Horiba Medical designs and manufactures automated in vitro diagnostic systems for hematology as well as chemistry focused analytical solutions. From compact point-of-care (POC) to high throughput systems, Horiba Medical has developed an array of analyzers and data management solutions to meet many needs, enabling analysis wherever it is required.

Related Links:
Horiba Medical


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.